Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions. For those who need relief, we must succeed—their hopes are our aspirations. We act with urgency, ingenuity and integrity as we seek a future free of seizures.
At Ovid, we are pursuing small molecule compounds with untapped potential. Applying our nimble, proven approach to accelerate clinical development, we aim to translate our molecules into first-in-class or best-in-class medicines. The patient, clinician and academic communities are our collaborators in every step of development from bench to bedside.
Our accomplished team holds a track record of success in making medicines for rare diseases and neurology. Our goal is bold for the communities we serve.
For more information, please visit www.ovidrx.com.
Review our community guidelines: http://www.ovidrx.com/community-guidelines/
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2014
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Ovid Therapeutics founded?
Ovid Therapeutics was founded in 2014.
What industry is Ovid Therapeutics in?
Ovid Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ovid Therapeutics based?
Ovid Therapeutics is headquartered in New York, United States.
Find investors for your startup like Ovid Therapeutics
Gritt sends AI-personalised outreach to each investor — from your Gmail
